Back to search
FDAFDA · Food and drugs·Recall number Z-1439-2014

Philips HeartStart XL+ Defibrillator/Monitor Model number: 861290, automatic external defibrillator.

Published April 16, 2014 · Recall initiated: March 31, 2014

Summary

FDA records medical device Class II recall Z-1439-2014, published April 16, 2014 and initiated March 31, 2014. Recalling firm: Philips Medical Systems, Inc.; Status: Terminated; Reported quantity: 19 units; Lot: Serial Numbers: USN1307680 USD1309181 USD1308456 USD1309182 USD1309167 USD1309184 USD1309168 USD1309194 USD1309180 USD1309195 USD1309196 USD1309274 USD1309197 USD1309286 USD1309227 USD1309301 USD1309264 US11409686 USD1309269. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A component on the HeartStart XL+ Therapy Board could malfunction potentially affecting the ability to deliver therapy

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Philips Medical Systems, Inc.
Distributor
Worldwide Distribution - US Distribution including the states of IN and WA., and the countries of : CHINA FRANCE GERMANY ITALY MALAYSIA PANAMA SAUDI ARABIA TURKEY and UNITED KINGDOM.
Lot
Serial Numbers: USN1307680 USD1309181 USD1308456 USD1309182 USD1309167 USD1309184 USD1309168 USD1309194 USD1309180 USD1309195 USD1309196 USD1309274 USD1309197 USD1309286 USD1309227 USD1309301 USD1309264 US11409686 USD1309269
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Philips HeartStart XL+ Defibrillator/Monitor Model number: 861290, automatic external defibrillator. recalled?

Yes. FDA published recall Z-1439-2014 on April 16, 2014. Reported hazard: A component on the HeartStart XL+ Therapy Board could malfunction potentially affecting the ability to deliver therapy

What should I do if I have this product?

Voluntary: Firm initiated · Letter